Data for: Potential cost-effectiveness of a maternal Group B streptococcal vaccine in The Gambia
Published: 26 April 2021| Version 3 | DOI: 10.17632/8v23fps2fz.3
Supplementary dat a of a cost effectiveness analysis of a potential hexavalent CPS-protein conjugate vaccine in the GAmbia. Further data to follow.
Vaccine, Health Economics